Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial.

ABSTRACT:

Background

Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it.

Objective

To investigate whether social app could be used to reduce warfarin-associated adverse events among post-MHVR Chinese patients.

Method

735 warfarin-treated patients (aged 50.8 ± 9.6 years, 59.9% female) were enrolled and randomized to a social app care group (warfarin therapy was guided by experienced clinicians via a social app) or a routine care group (warfarin therapy was managed through traditional in-office visits) at a 1 : 1 ratio. Ending points (bleeding and thrombotic events) were recorded during an 18-month follow-up period.

Results

A total of 718 patients were included in analysis. 57 of

SUBMITTER: Zhang L 

PROVIDER: S-EPMC9867580 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature